Alison co-heads our international Life Sciences and Healthcare group. She works with international life sciences companies to cut through the complexity of EU regulation of medical devices and pharmaceuticals, and get their products to market.

In a career of over 20 years, Alison has helped hundreds of life sciences companies manage the range of legal challenges involved in commercialising medical devices and medicinal products. She combines an encyclopaedic knowledge of the EU and UK life sciences regulatory environment with an analytical understanding of strategy and business in the life sciences sector. 

Alison provides sophisticated advice on regulation, compliance and commercialisation, as well as intellectual property transactions. On a number of occasions, she has successfully persuaded regulators and notified bodies to reconsider and ultimately overturn their decisions, allowing her clients to commercialise new products.

Alison supports clients on outright acquisitions and licences, as well as in due diligence for sizeable corporate transactions and listings. She also helps clients navigate the nuances of structuring and negotiating arrangements with various commercial and health care partners within the complex framework of EU regulations, national laws and industry and deontological codes. 

Her clients praise the pragmatism and commercial awareness she brings to every legal challenge and transaction, as well as her bright and personable working style. She is an accomplished leader, having built new life sciences practices for two top-tier London law firms.

显示完整简历 隐藏完整简历

最新新闻和观点

英国

Alison Dennis and Saleem Fazal recognised in The Lawyer's Hot 100 for 2022

2022年1月17日

作者

点击此处了解更多
技术、媒体与通信 (TMC)

Life sciences and healthcare in 2022 – legislators at work

2021年12月3日
Briefing

作者 Alison Dennis 以及 Justyna Ostrowska

点击此处了解更多
技术、媒体与通信 (TMC)

Digitalisation of healthcare – using technology to prioritise diversity in health products

2021年10月29日
Briefing

作者 Alison Dennis

点击此处了解更多
酒店与休闲

Proposed IVDR extended transition period: What it means for IVD manufacturers

2021年10月18日
Briefing

作者 Alison Dennis

点击此处了解更多

与我会面: